Combined with the verification in enlarged samples, we found that DIAPH2-AS1 was upregulated in NI-positive GC tissues and might function as the predictor factor for the diagnosis of GC-NI and the prognostic marker for GC patients. This evidence concerns the gene DIAPH2 and gastric cancer.